Fate Therapeutics (FATE) vs Palisade Bio (PALI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Fate Therapeutics (FATE) has outperformed Palisade Bio (PALI) over the past year, gaining 54.7% versus a loss of 11.9%. Over five years, FATE leads with a -96.5% price change compared with -99.9% for PALI. Palisade Bio is the larger company by market cap ($257.9 million vs $257.6 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FATE | PALI |
|---|---|---|
| Share price | $2.15 | $1.48 |
| Market cap | $257.61M | $257.92M |
| 1-day change | -6.11% | -0.67% |
| YTD return | +119.39% | -37.02% |
| 1-year return | +54.68% | -11.90% |
| 5-year return | -96.49% | -99.93% |
| P/E ratio (TTM) | — | 2.47 |
| EPS (TTM) | $-1.05 | $0.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.23 | $2.86 |
| 52-week low | $0.95 | $1.32 |
| Distance from 52-week high | -33.44% | -48.25% |
| Average volume | 1.90M | 2.64M |
| Shares outstanding | 119.82M | 174.27M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- FATE has outperformed PALI by 66.6 percentage points over the past year.
FATE vs PALI FAQ
Which is bigger, Fate Therapeutics or Palisade Bio?
Palisade Bio (PALI) is larger, with a market capitalization of $257.92M compared with $257.61M for Fate Therapeutics (FATE).
Which stock has performed better over the past year, FATE or PALI?
FATE returned +54.68% over the past 12 months, compared with -11.90% for PALI (price return, excluding dividends). Past performance does not predict future results.
Are Fate Therapeutics and Palisade Bio in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.